Cargando…
Targeted therapy using polymyxin B hemadsorption in patients with sepsis: a post-hoc analysis of the JSEPTIC-DIC study and the EUPHRATES trial
BACKGROUND: Polymyxin B hemadsorption (PMX-HA) reduces blood endotoxin levels, but characteristics of patients with sepsis likely to benefit from PMX-HA are not well known. We sought to identify patient subgroups likely to benefit from PMX-HA. METHODS: We retrospectively identified 1911 patients wit...
Autores principales: | Osawa, Itsuki, Goto, Tadahiro, Kudo, Daisuke, Hayakawa, Mineji, Yamakawa, Kazuma, Kushimoto, Shigeki, Foster, Debra M., Kellum, John A., Doi, Kent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286480/ https://www.ncbi.nlm.nih.gov/pubmed/37344804 http://dx.doi.org/10.1186/s13054-023-04533-3 |
Ejemplares similares
-
Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies
por: Kudo, Daisuke, et al.
Publicado: (2021) -
Web-based application for predicting the potential target phenotype for recombinant human thrombomodulin therapy in patients with sepsis: analysis of three multicentre registries
por: Goto, Tadahiro, et al.
Publicado: (2022) -
Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial
por: Klein, D. J., et al.
Publicado: (2018) -
Is polymyxin B-immobilized fiber column ineffective for septic shock? A discussion on the press release for EUPHRATES trial
por: Iba, Toshiaki, et al.
Publicado: (2017) -
Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study
por: Hayakawa, Mineji, et al.
Publicado: (2018)